Potential biomarkers of childhood brain tumor identified by proteomics of cerebrospinal fluid from extraventricular drainage (EVD)

[1]  Jian Zheng,et al.  lncRNA LINC00665 Stabilized by TAF15 Impeded the Malignant Biological Behaviors of Glioma Cells via STAU1-Mediated mRNA Degradation , 2020, Molecular therapy. Nucleic acids.

[2]  M. Prunotto,et al.  Neutrophil Extracellular Traps protein composition is specific for patients with Lupus nephritis and includes methyl-oxidized αenolase (methionine sulfoxide 93) , 2019, Scientific Reports.

[3]  S. Fagerholm,et al.  Cell Adhesion Molecules and Their Roles and Regulation in the Immune and Tumor Microenvironment , 2019, Front. Immunol..

[4]  M. Mann,et al.  Proteomics reveals NNMT as a master metabolic regulator of cancer associated fibroblasts , 2019, Nature.

[5]  M. Bookland,et al.  Peripheral biomarkers for pediatric brain tumors: current advancements and future challenges , 2019, Journal of Cancer Metastasis and Treatment.

[6]  I. Pollack,et al.  Childhood brain tumors: current management, biological insights, and future directions. , 2019, Journal of neurosurgery. Pediatrics.

[7]  The UniProt Consortium,et al.  UniProt: a worldwide hub of protein knowledge , 2018, Nucleic Acids Res..

[8]  R. Diaz-Arrastia,et al.  Biomarkers in traumatic brain injury (TBI): a review , 2018, Neuropsychiatric disease and treatment.

[9]  G. Tsangaris,et al.  Pediatric brain tumors: Update of proteome-based studies. , 2018, Journal of proteomics.

[10]  R. Packer,et al.  Pediatric Brain Tumors. , 2018, Neurologic clinics.

[11]  Ki-Chun Yoo,et al.  Proinvasive extracellular matrix remodeling in tumor microenvironment in response to radiation , 2018, Oncogene.

[12]  Samir S. Shah,et al.  Cerebrospinal Fluid Reference Values for Young Infants Undergoing Lumbar Puncture , 2018, Pediatrics.

[13]  J. Lathia,et al.  Revealing the glioma cancer stem cell interactome, one niche at a time , 2018, The Journal of pathology.

[14]  Hiromichi Suzuki,et al.  Significance of perivascular tumour cells defined by CD109 expression in progression of glioma , 2017, The Journal of pathology.

[15]  C. Catsman-Berrevoets,et al.  Validated age-specific reference values for CSF total protein levels in children. , 2017, European journal of paediatric neurology : EJPN : official journal of the European Paediatric Neurology Society.

[16]  David T. W. Jones,et al.  Pediatric Gliomas: Current Concepts on Diagnosis, Biology, and Clinical Management. , 2017, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[17]  L. Liotta,et al.  Proteomic analysis of cerebrospinal fluid from children with central nervous system tumors identifies candidate proteins relating to tumor metastatic spread , 2017, Oncotarget.

[18]  P. Díez,et al.  CSF analysis for protein biomarker identification in patients with leptomeningeal metastases from CNS lymphoma , 2017, Expert review of proteomics.

[19]  Jun Li,et al.  Thymosin beta 10 is a key regulator of tumorigenesis and metastasis and a novel serum marker in breast cancer , 2017, Breast Cancer Research.

[20]  Shaohua Tao,et al.  Elevated levels of cerebrospinal fluid S100B are associated with brain injury and unfavorable outcomes in children with central nervous system infections , 2017, The International journal of neuroscience.

[21]  An Wang,et al.  Thymosin beta 4 silencing suppresses proliferation and invasion of non-small cell lung cancer cells by repressing Notch1 activation. , 2016, Acta biochimica et biophysica Sinica.

[22]  J. Reijneveld,et al.  Prognostic value of the S100B protein in newly diagnosed and recurrent glioma patients: a serial analysis , 2016, Journal of Neuro-Oncology.

[23]  M. Grotzer,et al.  Targeting cerebrospinal fluid for discovery of brain cancer biomarkers , 2016 .

[24]  E. Diamandis,et al.  Identification of brain-enriched proteins in the cerebrospinal fluid proteome by LC-MS/MS profiling and mining of the Human Protein Atlas , 2016, Clinical Proteomics.

[25]  G. Reifenberger,et al.  The 2016 World Health Organization Classification of Tumors of the Central Nervous System: a summary , 2016, Acta Neuropathologica.

[26]  Norberto Andaluz,et al.  The Insertion and Management of External Ventricular Drains: An Evidence-Based Consensus Statement , 2016, Neurocritical Care.

[27]  N. S. Bhavesh,et al.  Structural delineation of stem-loop RNA binding by human TAF15 protein , 2015, Scientific Reports.

[28]  José A. Dianes,et al.  2016 update of the PRIDE database and its related tools , 2015, Nucleic Acids Res..

[29]  S. R. Snodgrass,et al.  A balanced view of the cerebrospinal fluid composition and functions: Focus on adult humans , 2015, Experimental Neurology.

[30]  J. Wiśniewski,et al.  Fast and sensitive total protein and Peptide assays for proteomic analysis. , 2015, Analytical chemistry.

[31]  Elizabeth M. Wells,et al.  Pediatric Brain Tumors , 2015, Continuum.

[32]  David T. W. Jones,et al.  Pilocytic astrocytoma: pathology, molecular mechanisms and markers , 2015, Acta Neuropathologica.

[33]  S. Ghodsi,et al.  Accuracy of magnetic resonance spectroscopy in distinction between radiation necrosis and recurrence of brain tumors , 2015, Iranian journal of neurology.

[34]  K. Aldape,et al.  Tumour suppressor TRIM33 targets nuclear β-catenin degradation , 2014, Nature Communications.

[35]  Marco Y. Hein,et al.  Accurate Protein Complex Retrieval by Affinity Enrichment Mass Spectrometry (AE-MS) Rather than Affinity Purification Mass Spectrometry (AP-MS)* , 2014, Molecular & Cellular Proteomics.

[36]  G. Tsangaris,et al.  The proteomics of pediatric brain tumors , 2014, Expert review of proteomics.

[37]  Yang Zhang,et al.  Proteomic analysis of cerebrospinal fluid: toward the identification of biomarkers for gliomas , 2014, Neurosurgical Review.

[38]  J. Rutka,et al.  Proteomic analyses of CSF aimed at biomarker development for pediatric brain tumors , 2014, Journal of Neuro-Oncology.

[39]  M. Mann,et al.  Minimal, encapsulated proteomic-sample processing applied to copy-number estimation in eukaryotic cells , 2014, Nature Methods.

[40]  M. Moschovi,et al.  Expression of heat shock proteins in medulloblastoma. , 2013, Journal of neurosurgery. Pediatrics.

[41]  L. Tora,et al.  TAF15 is important for cellular proliferation and regulates the expression of a subset of cell cycle genes through miRNAs , 2013, Oncogene.

[42]  H. Gomes.  Cerebrospinal fluid approach on neuro-oncology. , 2013, Arquivos de neuro-psiquiatria.

[43]  S. Karri,et al.  Biomarkers of Pediatric Brain Tumors , 2013, Front. Pediatr..

[44]  R. Donato,et al.  Functions of S100 proteins. , 2012, Current molecular medicine.

[45]  J. Whitin,et al.  Alterations in Cerebrospinal Fluid Proteins in a Presymptomatic Primary Glioma Model , 2012, PloS one.

[46]  Ron A. Wevers,et al.  Cerebrospinal Fluid Glucose and Lactate: Age-Specific Reference Values and Implications for Clinical Practice , 2012, PloS one.

[47]  K. Blennow,et al.  Peptidome Analysis of Cerebrospinal Fluid by LC-MALDI MS , 2012, PloS one.

[48]  R. Packer,et al.  Insights into pediatric diffuse intrinsic pontine glioma through proteomic analysis of cerebrospinal fluid. , 2012, Neuro-oncology.

[49]  R. Ralhan,et al.  14-3-3 zeta as novel molecular target for cancer therapy , 2012, Expert opinion on therapeutic targets.

[50]  Hamid Cheshmi.  Glioblastoma microvesicles transport RNA and proteins that promote tumour growth and provide diagnostic biomarkers , 2011 .

[51]  B. Zetter,et al.  Regenerative protein thymosin β‐4 is a novel regulator of purinergic signaling , 2011, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[52]  T. MacDonald,et al.  Proteomic profiling of cerebrospinal fluid identifies prostaglandin D2 synthase as a putative biomarker for pediatric medulloblastoma: A pediatric brain tumor consortium study , 2011, Proteomics.

[53]  Richard D. Smith,et al.  Establishing the Proteome of Normal Human Cerebrospinal Fluid , 2010, PloS one.

[54]  Johan Skog,et al.  Glioblastoma microvesicles transport RNA and protein that promote tumor growth and provide diagnostic biomarkers , 2008, Nature Cell Biology.

[55]  Thomas Brinker,et al.  Multiplicity of cerebrospinal fluid functions: New challenges in health and disease , 2008, Cerebrospinal Fluid Research.

[56]  D. Zurakowski,et al.  Urinary Biomarkers Predict Brain Tumor Presence and Response to Therapy , 2008, Clinical Cancer Research.

[57]  M. D. Den Boer,et al.  Identification of Novel Biomarkers in Pediatric Primitive Neuroectodermal Tumors and Ependymomas by Proteome-Wide Analysis , 2007, Journal of neuropathology and experimental neurology.

[58]  T. Inder,et al.  The Relationship of CSF and Plasma Cytokine Levels to Cerebral White Matter Injury in the Premature Newborn , 2005, Pediatric Research.

[59]  S. Nelson,et al.  Longitudinal multivoxel MR spectroscopy study of pediatric diffuse brainstem gliomas treated with radiotherapy. , 2004, International journal of radiation oncology, biology, physics.

[60]  M. Ichihara,et al.  Expression of CD109 in human cancer , 2004, Oncogene.

[61]  P. Marynen,et al.  Recurrent rearrangement of the Ewing's sarcoma gene, EWSR1, or its homologue, TAF15, with the transcription factor CIZ/NMP4 in acute leukemia. , 2002, Cancer research.

[62]  S. Cajal,et al.  Neuronal and mixed neuronal glial tumors associated to epilepsy. A heterogeneous and related group of tumours. , 2001, Histology and histopathology.

[63]  Vladimir Vapnik,et al.  An overview of statistical learning theory , 1999, IEEE Trans. Neural Networks.

[64]  H. Reiber.  Flow rate of cerebrospinal fluid (CSF) — A concept common to normal blood-CSF barrier function and to dysfunction in neurological diseases , 1994, Journal of the Neurological Sciences.

[65]  A. L. Albright,et al.  Pediatric brain tumors , 1993, CA: a cancer journal for clinicians.

[66]  C. Worster-Drought,et al.  Medulloblastoma (?) , 1931, Methods in Molecular Biology.

[67]  C. Teunissen,et al.  Guidelines for CSF Processing and Biobanking: Impact on the Identification and Development of Optimal CSF Protein Biomarkers. , 2019, Methods in molecular biology.

[68]  F. Vergani,et al.  Recent technological advances in pediatric brain tumor surgery. , 2017, CNS oncology.

[69]  C. Teunissen,et al.  The use of cerebrospinal fluid in biomarker studies. , 2017, Handbook of clinical neurology.

[70]  [World Health Organization classification of tumours of the central nervous system: a summary]. , 2016, Zhonghua bing li xue za zhi = Chinese journal of pathology.

[71]  Theodoros N. Arvanitis,et al.  Diagnosing relapse in children's brain tumors using metabolite profiles. , 2014, Neuro-oncology.

[72]  B. Zetter,et al.  Regenerative protein thymosin (cid:1) -4 is a novel regulator of purinergic signaling , 2011 .